Author:
Michels Karin B,zur Hausen Harald
Reference12 articles.
1. A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions;Dürst;Proc Natl Acad Sci USA,1983
2. A new type of papillomavirus DNA, its presence in genital cancer and in cell lines derived from genital cancer;Boshart;EMBO J,1984
3. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women;Paavonen;Lancet,2009
4. Einstein MH, on behalf of the HPV 010 study group. Immune response after primary vaccination course: a comparative trial of two HPV prophylactic vaccines. 25th International Papillomavirus Conference, Malmö, Sweden; May 8–14, 2009: O-01.02 (abstr).
5. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16–26 years;Wheeler;J Infect Dis,2009
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献